| Pediatric leukemia: Diagnosis to treatment–A review SC Bernard, EH Abdelsamad, PA Johnson, DL Chapman, ... Journal of Cancer Clinical trials 2 (2), 1, 2017 | 18 | 2017 |
| Role of lactoferrin in the carcinogenesis of triple-negative breast cancer SH Gopal, SK Das Journal of cancer clinical trials 1 (3), 2016 | 18 | 2016 |
| Endothelin: ominous player in breast cancer A Ratna, SK Das Journal of cancer clinical trials 1 (1), 2016 | 9 | 2016 |
| Endocrine therapy in epithelial ovarian cancer (EOC) New insights in an old target: A mini review AK Meszaros, VH Schwarz, M Vetter J Cancer Clin Trials 3 (144), 2577-0535.1000144, 2018 | 6 | 2018 |
| Novel genomics and proteomics based biomarkers to predict radiation response and normal radiotoxicity in cancer patients for personalized medicine HD Shukla J Cancer Clin Trials 1, 1-3, 2016 | 5 | 2016 |
| Rationale and Design of a Trial for Prophylactic Nutritional Support (Pronus) During Treatment for Head and Neck Cancer: A Single-Center, Randomized, Controlled Trial Comparing … MA Yusuf, F Zeb, MQ Khan, SR Hussain, H Mansoor J Cancer Clin Trials 1 (113), 2, 2016 | 5 | 2016 |
| A clearance step will become increasingly crucial for pretargeted tumor therapy when tumor accumulation is improved G Liu J. Cancer Clin. Trials 1 (106), 10.4172, 2016 | 5 | 2016 |
| Endometrial cancer with progestin and estrogen oral contraceptives and hormone therapy–a review and analysis of the current data EC Grant J Cancer Clin Trials 1, 114, 2016 | 4 | 2016 |
| Adjuvant therapy for resected exocrine pancreatic cancer by half-body low-dose irradiation JM Cuttler, P Garzon, REJ Mitchel, LE Feinendegen, K Sakamoto, ... J Cancer Clin Trials 1 (105), 2, 2016 | 4 | 2016 |
| Epithelial-to-mesenchymal transition as a potential target for antineoplastic therapies S Rao, A Jayachandran Journal of Cancer Clinical Trials, 2015 | 4 | 2015 |
| A review study on vaping and status of vaping in India V Thampi, R Nair, R Rawat, A Makhaik, S Dey J Cancer Clin Trials 3 (147), 2577-0535.1000147, 2018 | 3 | 2018 |
| Trans-fat food has more risk to cardiovascular disease than having effects as causative factors of Cancer O Bajinka, AO Touray, O Oyelakin J Cancer Clin Trials 2 (3), 134, 2017 | 3 | 2017 |
| Mitotic protein kinase 1: role in spindle assembly checkpoint revisited A Tandle, K Camphausen Journal of cancer clinical trials 1 (2), 2016 | 3 | 2016 |
| TRAF3 and CYLD Gene Defects in HPV-Associated Head and Neck Cancer: Biomarker of Response and Indicator of Targets for New Therapies N Issaeva, B Burtness, WG Yarbrough J. Cancer Clin. Trials 3, 1000142, 2018 | 2 | 2018 |
| Prostate cancer survivorship and psychosexual care: A systematic review for a continuously evolving field SS Goonewardene, A Young, R Persad, D Gillatt J Cancer Clin Trials 1 (1), 104, 2016 | 2 | 2016 |
| Commentary: Totally Implantable Venous-Access Ports Complications Associated with Cancer Patients H Osawa, Y Taura, H Akashi, H Endo, H Shiobara J Cancer Clin Trials 2 (133), 2, 2017 | 1 | 2017 |
| Cardiovascular status of patients after chemotherapy for haematological cancers in Jos Nigeria BN Okeahialam, SA Muoneme, OJ Egesie J Cancer Clin Trials 2 (127), 2, 2017 | 1 | 2017 |
| PET/CT Biological Imaging of Irradiation-Treated Tumors: Which Studies may Lead to an Improvement in Curability MJ Pelak J Cancer Clin Trials 1 (120), 2, 2016 | 1 | 2016 |
| Interstitial Pneumonitis in a Patient with Occult Sarcoidosis Treated with Pembrolizumab for Advanced Melanoma IJ Tan, J Bui, MA Khattak J Cancer Clin Trials 1 (116), 2, 2016 | 1 | 2016 |
| Outcomes of In-Hospital Cardiopulmonary Resuscitation among Cancer Patients: Experience from Pakistan W Zafar J Cancer Clin Trials 1 (107), 2, 2016 | 1 | 2016 |
Dr. Madhukiran ParvathaneniManager - Global Regulatory Affairs, CRC Pharma, New Jersey, USAVerified email at crcpharma.com
